Free Trial
NASDAQ:ALVR

AlloVir (ALVR) Stock Price, News & Analysis

AlloVir logo
$2.42 -0.04 (-1.63%)
As of 07/17/2025

About AlloVir Stock (NASDAQ:ALVR)

Key Stats

Today's Range
$2.35
$2.52
50-Day Range
$2.36
$3.54
52-Week Range
$7.96
$24.15
Volume
203,569 shs
Average Volume
15,511 shs
Market Capitalization
$12.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter.

ALVR Stock News Headlines

Kalaris Announces Closing of Merger with AlloVir
Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
Kalaris, AlloVir announce stockholder approval of merger
Allovir's Vikas Sinha sells shares worth $3,052
See More Headlines

ALVR Stock Analysis - Frequently Asked Questions

AlloVir's stock was trading at $9.66 on January 1st, 2025. Since then, ALVR stock has decreased by 74.9% and is now trading at $2.42.

AlloVir, Inc. (NASDAQ:ALVR) posted its earnings results on Wednesday, August, 14th. The company reported ($1.15) earnings per share for the quarter, topping the consensus estimate of ($2.30) by $1.15.

Shares of AlloVir reverse split before market open on Thursday, January 16th 2025.The 1-23 reverse split was announced on Wednesday, January 15th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

AlloVir (ALVR) raised $252 million in an initial public offering (IPO) on Thursday, July 30th 2020. The company issued 14,800,000 shares at $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, SVB Leerink and Piper Sandler served as the underwriters for the IPO.

Shares of ALVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AlloVir investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/14/2024
Today
7/18/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALVR
CIK
1754068
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($20.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-71.03%
Return on Assets
-61.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
86.78
Quick Ratio
86.78

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$29.35 per share
Price / Book
0.08

Miscellaneous

Outstanding Shares
5,043,000
Free Float
3,425,000
Market Cap
$12.41 million
Optionable
Optionable
Beta
0.63
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ALVR) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners